资源描述:
《[精品]重组人胰岛素注射液治疗糖尿病74例的临床分析.doc》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、重组人胰岛素注射液治疗糖尿病74例的临床分析重组人胰岛素注射液治疗糖尿病74例的临床分析【摘耍】目的:观察重组人胰岛素注射液治疗糖尿病的临床疗效。方法:将148例确诊为糖尿病的患者随机分为对照组和观察组,每组74例。在常规治疗的基础上,对照组采用中效人胰岛素(诺和灵30R)进行治疗,观察组采用重组人胰岛素注射液(优泌林30R)进行治疗,比较两组治疗前后空腹血糖、餐后2h血糖、糖化血红蛋白、总胆固醇、低密度脂蛋白胆固醇水平以及胰岛素抵抗指数等指标。结果:经过4个月治疗后,观察组和对照组的空腹血糖分别降低至(5.68±0.26)mmol/L和(6.83±0.41)mmol/L;餐后2h血糖
2、分别降低至(6.81+0.58)mmol/L和(8.83+0.43)mmoL/L;糖化血红蛋白分别降低至(5.38±0.17)%和(7.42±0・22)%。与治疗前比较,两组空腹血糖、餐后2h血糖、糖化血红蛋白以及其他临床指标如总胆固醇、低密度脂蛋白胆固醇水平等均得到显著改善,差异有统计学意义(P〈0.05),但观察组改善更加明显,与对照组比较,差异有统计学意义(卩〈0・05)。结论:重组人胰岛索注射液治疗糖尿病临床疗效显著,安全性较高,值得临床上推广应用。【关键词]重组人胰岛素注射液;糖尿病;临床疗效【Abstract】Objective:Toobservetheclinicalef
3、fectofrecombinanthumaninsulininjectionintreatmentofdiabetes,toprovidetheexperimentaldataandtheoreticalsupportforthefutureclinicalwork・Method:148patientswithdiabetesweredividedintocontrolgroupandobservationgrouprandomly,74casesineachgroup・Onthebasisofconventionaltreatment,thecontrolgroupweretreat
4、edwithinsulin(gnosis30r),theobservationgroupweretreatedwithrecombinanthumaninsulininjection(optimalsecreteLin30r)・Fastingbloodglucosebeforeandafterthetreatment,2hpostprandialbloodglucose,glycosylatedhemoglobin,totalcholesterol,lowdensityesterprotein,cholesterolandinsulinresistanceindexandotherin
5、dicatorsintwogroupswerecompared・Result:Afterfourmonthsaftertreatment,thefastingbloodglucoseinobservationgroupandcontrolgroupwerereducedto(5.68±0.26)mmol/Land(6.83+0.41)mmol/L;2hbloodglucoseaftermealinobservationgroupandcontrolgroupwerereducedto(6.81±0.58)mmol/Land(8.83+0.43)mmol/L;glycosylatedhe
6、moglobinwerereducedto(5.38±0.17)%and(7.42+0.22)%.Comparedwithbeforetreatment,fastingbloodglucose,2hpostprandialbloodglucose,glycosylatedhemoglobin,andotherclinicalindicatorssuchastotalcholesterol,lowdensityesterproteinsuchascholesterollevelsoftwogroupsweresignificantlyimproved,thediffereneewasst
7、atisticallysignificant(P<0.05),buttheobservationgroupimprovedmoresignificantly,comparedwithcontrolgroup,thedifferencewasstatisticallysignificant(P<0.05).Conclusion:Theclinicalcurativeeffectofrecombinanthumaninsulininjectioni